Cellebrite director Dafna Gruber reports 27,919 shares

Cellebrite DI Ltd. director Dafna Gruber filed an initial ownership report showing beneficial ownership of 27,919 Ordinary Shares.

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Dafna Gruber filed an initial ownership report showing beneficial ownership of 27,919 Ordinary Shares. This total includes 10,601 Ordinary Shares represented by restricted share units granted on September 17, 2025 that vest on September 17, 2026, with each RSU settling into one Ordinary Share.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gruber Dafna

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	--	--	--

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") — 27,919 shares (Direct)

Footnotes (1)

1. F1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dafna Gruber’s Form 3 filing show for Cellebrite (CLBT)?

The Form 3 shows director Dafna Gruber beneficially owns 27,919 Ordinary Shares of Cellebrite. This is an initial ownership report, not a buy or sell transaction, and establishes her starting equity position as a company insider.

How many Cellebrite (CLBT) shares are held through RSUs by Dafna Gruber?

The filing states 10,601 of the reported Ordinary Shares are represented by restricted share units. These RSUs were granted on September 17, 2025 and will vest on September 17, 2026, each converting into one Ordinary Share upon settlement.

Is Dafna Gruber’s ownership in Cellebrite (CLBT) direct or indirect?

The Form 3 indicates her 27,919 Ordinary Shares are held as direct ownership. The nature of ownership field is marked as direct, meaning the position is attributed personally to Dafna Gruber rather than through a separate entity or trust.

Does Dafna Gruber’s Cellebrite (CLBT) Form 3 reflect any recent trades?

No trades are described; the entry is categorized as a holding, not a transaction. Form 3 is used to report an insider’s initial beneficial ownership when they become a reporting person, establishing their baseline share position in the company.

When do Dafna Gruber’s Cellebrite (CLBT) RSUs vest?

According to the footnote, the 10,601 restricted share units were granted on September 17, 2025 and are scheduled to vest on September 17, 2026. Upon vesting and settlement, each RSU entitles her to receive one Ordinary Share of Cellebrite.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 08:11 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gruber Dafna

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	27,919(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

	/s/ Dafna Gruber	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)